Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditions.

Cardiovascular research - 1 Jul 2016

Layne Kerry, Di Giosia Paolo, Ferro Albert, Passacquale Gabriella

Abstract excerpt

AIMS: Levels of circulating CD14(high)CD16(+) monocytes increase in atherosclerotic patients and are predictive of future cardiovascular events. Platelet activation has been identified as a crucial determinant in the acquisition of a CD16(+) phenotype by classical CD14(high)CD16(-) cells. We tested the hypothesis that anti-platelet drugs modulate the phenotype of circulating monocytes. METHODS AND RESULTS: Sixty...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspirin
Share to Clopidogrel
Share to Immunologic Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Influenza Vaccines

Share to Lipopolysaccharide Receptors

Share to London

Share to P-Selectin

Share to Ticlopidine

Source

Open in PubMed Open full text

Identifiers

PMID: 27118470
DOI: 10.1093/cvr/cvw089
PMCID: PMC4909161

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditions.PMID 27118470Read ↗

Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes.Semantic proximity Read ↗

Activated Platelets Convert CD14+CD16- Into CD14+CD16+ Monocytes With Enhanced FcγR-Mediated Phagocytosis and Skewed M2 Polarization.Semantic proximity Read ↗

Elevated CD14++CD16- monocytes predict cardiovascular events.Semantic proximity Read ↗

The "Intermediate" CD14++CD16+ monocyte subset increases in severe peripheral artery disease in humans.Semantic proximity Read ↗

Nonclassical monocytes in cardiovascular physiology and disease.Semantic proximity Read ↗

Monocyte subtypes predict clinical course and prognosis in human stroke.Semantic proximity Read ↗

Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney diseaseSemantic proximity Read ↗

Peripheral blood CD14high CD16+ monocytes are main producers of IL-10.Semantic proximity Read ↗

SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subsetSemantic proximity Read ↗

CD14+CD16++ "nonclassical" monocytes are associated with endothelial dysfunction in patients with coronary artery disease.Semantic proximity Read ↗

The role of monocyte phenotype switching in peri-procedural myocardial injury and its involvement in statin therapy.Semantic proximity Read ↗

Xuemaitong granules attenuate carotid atherosclerosis by decreasing the expression of CD14+CD16+ monocytes, IL-6, TNF-α, and hsCRP.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.